Valeant drama continues
The pharmaceutical giant is going to be a focus today. Shares are halted for the announcement.
– 2015 misstatements cut revenue by $21 million and boosted EPS by 7-cents
Scandals like Valeant are why people hate the stock market. So many lies, financial irregularities and inside info.
